Biotechnology

Techseriesinsight > Blog > News > Biotechnology

December 18, 2024
Business Wire
Biotechnology

Sensorion Reports Data in the Audiogene Phase 1/2 Gene Therapy Clinical Trial

Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, announced today latest data updates confirming...

December 17, 2024
Business Wire
Biotechnology

Soilytix Pioneers Breakthrough in Soil Microbiome Research for Global Crop Yield Predictions

Soilytix GmbH, a leading innovator in soil microbiome analytics, announces a groundbreaking study recently published in Science of the Total Environment. The research, titled “Local Microbial Yield-Associating Signatures Largely Extend...

December 16, 2024
PRNewswire
Biotechnology

Promise Bio Emerges from Stealth with $8.3M Seed Investment to Transform Precision Medicine for Immune-Mediated Diseases

Promise Bio, a startup transforming immune-mediated disease treatment with advanced precision medicine solutions, today announced its emergence from stealth with an $8.3 million seed investment. This funding will accelerate the development...

December 16, 2024
Business Wire
Biotechnology

Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelerate ADC Development

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotech company focusing on the discovery of novel antibody/ADC therapeutics, announced that Adcendo ApS (“Adcendo”), a biotech company focused...

December 16, 2024
PRNewswire
Biotechnology

Nona Biosciences Announces Discovery Collaboration with Candid Therapeutics for Next-Generation T-Cell Engagers

Nona Biosciences, a global biotechnology company providing a total solution from “Idea to IND” (I to ITM), today announced a research collaboration and license agreement to discover next-generation T-cell engagers (“TCEs”)...

December 6, 2024
PRNewswire
Biotechnology

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on December 2, 2024, the Compensation Committee of IDEAYA’s...

December 6, 2024
PRNewswire
Biotechnology

Another star technology platform of the Sanyou AI-STAL family

With the announcement of the 2024 Nobel Prize in Physiology or Medicine, microRNA has once again become the focus of global attention. In the past 20 years, three Nobel Prizes...

December 6, 2024
Business Wire
Biotechnology

Alithea Genomics Launches Full-Length DRUG-Seq to Unlock Full Power of Transcriptomics for Drug Discovery

Alithea Genomics, a leader in the field of large-scale RNA sequencing and transcriptomics, announced today the launch of MERCURIUS™ Full-Length DRUG-seq library preparation technology, which combines, for the first...

December 5, 2024
PRNewswire
Biotechnology

Ariceum Therapeutics and Eckert & Ziegler Sign Global Supply Agreement for the Development of Next-Generation Radiotherapeutics for Precision Cancer Treatments

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, and Eckert & Ziegler, one of the world’s largest providers...

December 5, 2024
Business Wire
Biotechnology

FDA Accepts Supplemental Biologics License Application for Genentech’s Columvi Combination for People With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License...